Helping people to fall in travellove and get paid for it
Luxury Destination Specialist
Location
United States + 30 moreAll locations: United States, Brazil, Colombia, Argentina, Chile, Venezuela, Bolivarian Republic Of, Bolivia, Plurinational State Of, Ecuador, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Mexico, Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, Panama, Dominican Republic, Puerto Rico, Bahamas, Guadeloupe, Haiti, Jamaica, Martinique, Montserrat
Posted
5 days ago
Salary
Not specified
Job Description
Role Description
Do you have a passion for travel, a flair for luxury, and a desire to build a flexible career from anywhere in the world? We’re seeking motivated individuals to join our global team as Luxury Destination Specialists, helping clients plan unforgettable experiences.
No prior experience? No problem. We provide full training, mentorship, and access to world-class tools to help you succeed.
As a Luxury Destination Specialist, you will:
- Use our professional booking platform to curate and sell exclusive travel experiences including hotels, cruises, tours, excursions, events, and concerts and sports events worldwide.
- Provide personalized recommendations and concierge-level service to clients.
- Build and manage your own client portfolio.
- Participate in ongoing training, mentorship, and personal development.
- Collaborate with a supportive community of travel professionals.
- Promote exclusive travel offers and earn commissions on bookings.
Qualifications
- Passionate about travel, luxury, and helping others.
- Self-motivated and eager to learn.
- Comfortable working independently and remotely.
- Strong communication and interpersonal skills.
- Reliable internet connection and laptop or similar device.
- Positive attitude and entrepreneurial mindset.
Benefits
- Access to a global booking platform with luxury travel inventory.
- Comprehensive training and mentorship - no experience required.
- Personal development and business coaching.
- Supportive team culture.
- Bonus: Earn a free cruise for two through performance-based incentives.
- Flexible schedule - work remotely from anywhere with Wi-Fi.
Company Description
Job Requirements
- Passionate about travel, luxury, and helping others.
- Self-motivated and eager to learn.
- Comfortable working independently and remotely.
- Strong communication and interpersonal skills.
- Reliable internet connection and laptop or similar device.
- Positive attitude and entrepreneurial mindset.
Benefits
- Access to a global booking platform with luxury travel inventory.
- Comprehensive training and mentorship - no experience required.
- Personal development and business coaching.
- Supportive team culture.
- Bonus: Earn a free cruise for two through performance-based incentives.
- Flexible schedule - work remotely from anywhere with Wi-Fi.
Related Guides
Related Job Pages
More Sales Jobs
Discovery Diagnostic Sales Specialist
Danaher CorporationAt SCIEX, we believe in designing a better, more sustainable workforce. We recognize the benefits of flexible, remote working arrangements for eligible roles and are committed to providing enriching careers, no matter the work arrangement. The Salary Range for this role is $100,000 - $120,000, with total compensation target of $180,000 - $200,000 annually. Danaher Corporation and all Danaher Companies are committed to equal opportunity regardless of race, color, national origin, religion, sex, age, marital status, disability, veteran status, sexual orientation, gender identity, or other characteristics protected by law.
The Diagnostic Sales Specialist will serve as the primary Cytiva solutions provider for all diagnostic application needs within the assigned territory, developing and executing a strategic territory plan to drive annual account growth. This role involves owning accurate sales forecasting, pursuing new business opportunities, leading pricing negotiations, and collaborating with R&D and technical teams to deliver optimal solutions.
Senior/Advanced Lung Disease Specialist (Akron, OH) *Rare Disease Opportunity*
United Therapeutics CorporationWe are the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation. Our public benefit purpose is to provide a brighter future for patients through the development of novel pharmaceutical therapies; and technologies that expand the availability of transplantable organs. United Therapeutics (Nasdaq: UTHR) seeks to travel down the corridors of indifference to develop treatments for rare, deadly diseases. We were founded in 1996 by a family seeking a cure for their daughter’s pulmonary arterial hypertension (PAH). Today, we have six FDA-approved therapies that treat PAH, pulmonary hypertension associated with interstitial lung disease (PH-ILD) and neuroblastoma, a rare pediatric cancer. Our near-term pipeline seeks to develop additional therapies for PAH and pulmonary fibrosis (PF). The cure for end-stage life-threatening diseases like PAH, PH-ILD, PF, and many others is an organ transplant, but only a small percentage of donated organs are available to address the vast need. For this reason, we are working to create manufactured organs to address the shortage of kidneys, hearts, lungs, and livers available for transplant. We believe an unlimited supply of tolerable, transplantable organs will eliminate the transplant waiting list and cure end-stage organ diseases for which transplant is not currently an option.
The Advanced Lung Disease (ALD) Specialist is responsible for maintaining and increasing sales of all UT products, primarily Tyvaso, within a defined territory by executing sales and marketing strategies and serving as an educational resource for healthcare professionals treating PH-ILD and/or IPF patients. This involves building professional relationships with various customer types, analyzing sales reports to develop business plans, and ensuring maximal product messaging and education across the assigned geographic territory.
Senior/Advanced Lung Disease Specialist (Rochester, MN) *Rare Disease Opportunity*
United Therapeutics CorporationWe are the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation. Our public benefit purpose is to provide a brighter future for patients through the development of novel pharmaceutical therapies; and technologies that expand the availability of transplantable organs. United Therapeutics (Nasdaq: UTHR) seeks to travel down the corridors of indifference to develop treatments for rare, deadly diseases. We were founded in 1996 by a family seeking a cure for their daughter’s pulmonary arterial hypertension (PAH). Today, we have six FDA-approved therapies that treat PAH, pulmonary hypertension associated with interstitial lung disease (PH-ILD) and neuroblastoma, a rare pediatric cancer. Our near-term pipeline seeks to develop additional therapies for PAH and pulmonary fibrosis (PF). The cure for end-stage life-threatening diseases like PAH, PH-ILD, PF, and many others is an organ transplant, but only a small percentage of donated organs are available to address the vast need. For this reason, we are working to create manufactured organs to address the shortage of kidneys, hearts, lungs, and livers available for transplant. We believe an unlimited supply of tolerable, transplantable organs will eliminate the transplant waiting list and cure end-stage organ diseases for which transplant is not currently an option.
The Advanced Lung Disease Specialist is responsible for maintaining and increasing sales of all UT products, primarily Tyvaso, within a defined territory by executing sales and marketing strategies and serving as an educational resource for healthcare professionals treating PH-ILD and/or IPF.
Senior/Advanced Lung Disease Specialist (Ann Arbor, MI) *Rare Disease Opportunity*
United Therapeutics CorporationWe are the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation. Our public benefit purpose is to provide a brighter future for patients through the development of novel pharmaceutical therapies; and technologies that expand the availability of transplantable organs. United Therapeutics (Nasdaq: UTHR) seeks to travel down the corridors of indifference to develop treatments for rare, deadly diseases. We were founded in 1996 by a family seeking a cure for their daughter’s pulmonary arterial hypertension (PAH). Today, we have six FDA-approved therapies that treat PAH, pulmonary hypertension associated with interstitial lung disease (PH-ILD) and neuroblastoma, a rare pediatric cancer. Our near-term pipeline seeks to develop additional therapies for PAH and pulmonary fibrosis (PF). The cure for end-stage life-threatening diseases like PAH, PH-ILD, PF, and many others is an organ transplant, but only a small percentage of donated organs are available to address the vast need. For this reason, we are working to create manufactured organs to address the shortage of kidneys, hearts, lungs, and livers available for transplant. We believe an unlimited supply of tolerable, transplantable organs will eliminate the transplant waiting list and cure end-stage organ diseases for which transplant is not currently an option.
The Advanced Lung Disease (ALD) Specialist is responsible for maintaining and increasing sales of all UT products, primarily Tyvaso, within a defined territory by executing sales and marketing strategies and serving as an educational resource for healthcare professionals treating PH-ILD and/or IPF.
